Clinical trial
Retrospective Study on Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia (CML) in Kuwait
NCT07454850 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study on Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia (CML) in Kuwait
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 30, 2026
- Completion date
- March 30, 2027
- Enrollment
- 400 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.